Liu T, Luo S, Yuan X, Liu D, et al. Trastuzumab Rezetecan in Human Epidermal Growth Factor Receptor 2-Expressing
Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma and
Colorectal Cancer: A Multicenter, Open-Label, Phase I Trial. J Clin Oncol 2026 Mar 4:JCO2500716. doi: 10.1200/JCO-25-00716.
PMID: 41779980
|